Panel Votes Against Medtronic’s Chronicle, Offers Ideas For New Trial

FDA's Circulatory System Devices Panel offered Medtronic advice on how to design a new trial for its Chronicle implantable hemodymanic monitor after voting against approval of the product's PMA

More from Archive

More from Medtech Insight